These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 4249087

  • 1. Relationship of nicotinamide and nicotinic acid to hypolipidemia.
    Dalton C, VanTrabert TC, Dwyer JX.
    Biochem Pharmacol; 1970 Sep; 19(9):2609-19. PubMed ID: 4249087
    [No Abstract] [Full Text] [Related]

  • 2. Antilipaemic effect of nicotinamide.
    Dalton C.
    Nature; 1967 Nov 25; 216(5117):825. PubMed ID: 4229354
    [No Abstract] [Full Text] [Related]

  • 3. Observations on the cholesterol-lowering mechanism of nicotinic acid and nicotinyl alcohol tartrate.
    Alton C, Kowalski C, Mallon J, Marschhaus C.
    J Atheroscler Res; 1968 Nov 25; 8(2):265-76. PubMed ID: 5664196
    [No Abstract] [Full Text] [Related]

  • 4. Acute effects on plasma lipids in the rat of a new long-acting nicotinic acid derivative: LG 13979.
    Subissi A, Criscuoli M, Biagi M, Murmann W.
    J Pharm Pharmacol; 1983 Sep 25; 35(9):571-5. PubMed ID: 6138406
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the antilipemic effect of nicotinic acid (NA) and 3-methylpyrazole-5-carboxylic acid (MPC) in rats.
    Tamási G, Borsy J, Patthy A.
    Biochem Pharmacol; 1968 Sep 25; 17(9):1789-94. PubMed ID: 5688267
    [No Abstract] [Full Text] [Related]

  • 6. Subacute administration of pentaerythritoltetranicotinate (Perycit) to man.
    Harthon L, Svedmyr N.
    Atherosclerosis; 1974 Sep 25; 20(1):65-8. PubMed ID: 4617581
    [No Abstract] [Full Text] [Related]

  • 7. The pharmacology of 5-(3-pyridyl)tetrazole, a hypocholesteremic lipolysis inhibitor.
    Pereira JN, Holland GF, Hochstein FA, Gilgore S, Defelice S, Pinson R.
    J Pharmacol Exp Ther; 1968 Jul 25; 162(1):148-54. PubMed ID: 5690452
    [No Abstract] [Full Text] [Related]

  • 8. The effect of nicotinamide adenine dinucleotide on lipolysis in adipose tissue in vitro.
    Perpeira JN, Holland GF.
    Experientia; 1966 Oct 15; 22(10):658-9. PubMed ID: 4382023
    [No Abstract] [Full Text] [Related]

  • 9. Different responses of white and brown adipose tissue to drugs affecting lipolysis.
    Bizzi A, Codegoni AM, Lietti A, Garattini S.
    Biochem Pharmacol; 1968 Dec 15; 17(12):2407-12. PubMed ID: 4305303
    [No Abstract] [Full Text] [Related]

  • 10. Effect of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia during the first week of treatment.
    Carlson LA, Orö L, Ostman J.
    J Atheroscler Res; 1968 Dec 15; 8(4):667-77. PubMed ID: 5679950
    [No Abstract] [Full Text] [Related]

  • 11. [Arteriosclerosis--nicotinic acid therapy. 11. Nicotinic acid and tissue triglycerides].
    Fröberg SO.
    Lakartidningen; 1971 Apr 07; 68(15):1773-5. PubMed ID: 5577253
    [No Abstract] [Full Text] [Related]

  • 12. Lowering of serum lipid levels by "masked" nicotinic acid derivatives.
    Bailey DM, Wood D, Johnson RE, McAuliff JP, Bradford JC, Arnold A.
    J Med Chem; 1972 Apr 07; 15(4):344-8. PubMed ID: 5019547
    [No Abstract] [Full Text] [Related]

  • 13. The hypersensitivity of adipose tissue to norepinephrine and other lipolytic agents during blockade of free fatty acids (FFA) mobilization.
    Bizzi A, Codegoni AM, Garattini S.
    Biochem Pharmacol; 1969 Sep 07; 18(9):2053-60. PubMed ID: 4310274
    [No Abstract] [Full Text] [Related]

  • 14. Cyclic adenosine 3',5'-monophosphate and enylcyclase in liver, adipose tissue and brain of rats treated with beta-pyridylcarbinol.
    Burkard WP, Lengsfeld H, Gey KF.
    Biochem Pharmacol; 1971 Jan 07; 20(1):23-8. PubMed ID: 4328274
    [No Abstract] [Full Text] [Related]

  • 15. Changes in serum triglyceride and cholesterol levels independently of free fatty acid after lipolysis inhibitors.
    Tamási G, Borsy J, Gyenge R.
    Biochem Pharmacol; 1970 May 07; 19(5):1826-30. PubMed ID: 5513963
    [No Abstract] [Full Text] [Related]

  • 16. [Arteriosclerosis--nicotinic acid therapy. 12. Some effects on experimental animals].
    Brattsand R, Lindström E.
    Lakartidningen; 1971 Apr 07; 68(15):1776-82. PubMed ID: 4325229
    [No Abstract] [Full Text] [Related]

  • 17. [Arteriosclerosis--nicotinic acid therapy. 3. Lipolytic effects of nicotinic acid and its derivatives].
    Lundholm L.
    Lakartidningen; 1971 Apr 07; 68(15):1746-9. PubMed ID: 5577245
    [No Abstract] [Full Text] [Related]

  • 18. Effect of NAD, nicotinamide and nicotinic acid on cyclic AMP accumulation by fat cells.
    Moreno FJ, Shepherd RE, Fain JN.
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar 07; 306(2):179-83. PubMed ID: 221845
    [No Abstract] [Full Text] [Related]

  • 19. [The mode of action of nicotinic acid on the transport of lipids].
    Puglisi L, Solyom A, Usardi MM, Vertua R, Paoletti R.
    Pathol Biol; 1967 Feb 07; 15(3):204-8. PubMed ID: 4860731
    [No Abstract] [Full Text] [Related]

  • 20. [Daily profile of blood lipids under standardized diet with and without nicotinic acid].
    Mühlfellner G, Mühlfellner O, Zöfel P, Kaffarnik H.
    Verh Dtsch Ges Inn Med; 1976 Feb 07; 82 Pt 1():810-2. PubMed ID: 1029288
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.